Serological Monitoring of Gestational Toxoplasmosis: Retrospective Analysis of Pregnant Women in Petrópolis, RJ, Brazil
DOI:
https://doi.org/10.17696/2318-3691.31.01.2025.226Keywords:
prenatal care, gestational toxoplasmosis, ; serology, ToxoplasmaAbstract
Introduction: Congenital toxoplasmosis is one of the most serious forms of Toxoplasma gondii infection, acquired by the fetus when pregnant women are infected, at the beginning of pregnancy or close to conception. Therefore, diagnosis, monitoring, and guidance during prenatal care are essential factors to help reduce the number of cases of this disease and its consequences. Objectives: To evaluate the serological monitoring of gestational toxoplasmosis during prenatal care based on data collected from medical records of postpartum women treated at a public hospital in Petrópolis city, Rio de Janeiro state, Brazil, between 2020 and 2022. Methods: Pregnant women were divided into four groups, according to the number of serological tests they were subjected to during prenatal care. Variables related to mother, pregnancy, and prenatal care were analyzed and compared between groups. Results: In total, 240 (39.9%) of the 602 analyzed medical records presented IgG antibodies, whereas eight (1.3%) of them showed IgM antibodies; 16 (2.7%) of patients were subjected to four serological tests during pregnancy; 115 (19.1%) of them were subjected to three tests; 214 (35.5%), to two tests; and 257 (42.7%) of patients only underwent one test. Group 4 was the only group in which all susceptible pregnant women underwent all three serological tests following the initial test. Consequently, the number of toxoplasmosis tests conducted decreased as pregnancy progressed. Conclusions: Based on the analyzed data, approximately 60% of pregnant women were susceptible to infection caused by Toxoplasma gondii, and many were not monitored as recommended by the Ministry of Health."*
References
Peyron F, L’Ollivier C, Mandelbrot L, Wallon M, Piarroux R, Kieffer F, et al. Maternal and congenital toxoplasmosis: diagnosis and treatment recommendations of a French multidisciplinary working group. Pathogens. 2019;8(1):24. doi:10.3390/pathogens8010024.
2. Rostami A, Riahi SM, Contopoulos-Ioannidis DG, Gamble HR, Fakhri Y, Shiadeh MN, et al. Acute Toxoplasma infection in pregnant women worldwide: a systematic review and metaanalysis. PLoS Negl Trop Dis. 2019;13(10):e0007807. doi:10.1371/journal.pntd.0007807.
3. Bollani L, Auriti C, Achille C, Garofoli F, De Rose DU, Meroni V, et al. Congenital Toxoplasmosis: the state of the art. Front Pediatr. 2022;10:894573. doi:10.3389/fped.2022.894573.
4. Amendoeira MRR. Mecanismos de transmissão da toxoplasmose. Na Acad Nac Med.1995;155(4):224-5.
5. Shapiro K, Bahia-Oliveira L, Dixon B, Dumètre A, Wit LA, Vanwormer E, et al. Environmental transmission of Toxoplasma gondii: oocysts in water, soil and food. Food Waterborne Parasitol. 2019;15:e00049. doi: 10.1016/j.fawpar.2019.e00049.
6. Strang A, Ferrari RG, Rosário DK, Nishi L, Evangelista FF, Santana PL, et al. The congenital toxoplasmosis burden in Brazil: systematic review and meta-analysis. Acta Trop. 2020;211:105608. doi:10.1016/j.actatropica.2020.105608.
7. Franco PS, Scussel ACMO, Silva RJ, Araújo TE, Gonzaga HT, Marcon CF, et al. Systematic Review and Meta-Analysis of Congenital Toxoplasmosis Diagnosis: Advances and Challenges. J Trop Med. 2024. doi:10.1155/2024/1514178.
8. Paschoal ATP, Bernardes JC, Nadal AL, Vilas Boas JS, Silva ACS, Monica TC, et al. Evaluation of implementation of the primary, secondary and tertiary prevention measures of the Surveillance Program of Gestational and Congenital Toxoplasmosis in the city of Londrina-PR. Transbound Emerg Dis. 2021;69(3):1449-57. doi:10.1111/tbed.14111.
9. Secretaria de Estadual de Saúde. Protocolo estadual de atenção ao pré-natal de risco habitual [Internet]. Rio de Janeiro: SES; 2020 [2023 Oct 20]. 138 p. Available from: https://saude.rj.gov.br/comum/code/MostrarArquivo.php?C=MzU0MjY%2C
10. Ministério da Saúde. Portaria nº 204/2016. Define a Lista Nacional de Notificação Compulsória de doenças, agravos e eventos de saúde pública nos serviços de saúde públicos e privados em todo o território nacional, nos termos do anexo, e dá outras
providências [Internet]. [cited 2023 Nov 4]. Available from: https://bvsms.saude.gov.br/bvs/saudelegis/gm/2016/prt0204_17_02_2016.html
11. Dubey JP, Murata FHA, Cerqueira-Cézar CK, Kwok OCH, Villena I. Congenital toxoplasmosis in humans: an update of worldwide rate of congenital infections. Parasitol. 2021;148(12):1406-16. doi:10.1017/S0031182021001013.
12. Kim K, Weiss LM. Toxoplasma gondii: the model apicomplexan. Int J Parasitol. 2004;34(3):423-32. doi:10.1016/j.ijpara.2003.12.009.
13. Bigna JJ, Tochie JN, Tounouga DN, Bekolo AO, Ymele NS, Youda EL, et al. Global, regional,and country seroprevalence of Toxoplasma gondii in pregnant women: a systematic review,modelling and meta-analysis. Scientif Rep. 2020;10:12102. doi:10.1038/s41598-020-69078-9.
14. Oliveira GMS, Simões JM, Schaer RE, Freire SM, Nascimento RJM, Pinheiro AMCM, et al.Frequency and factors associated with Toxoplasma gondii infection in pregnant womenand their pets in Ilhéus, Bahia, Brazil. Rev Soc Bras Med Trop. 2019;52:e20190250.
doi:10.1590/0037-8682-0250-2019.
15. Evangelista FF, Mantelo FM, Lima KK, Marchioro AA, Beletini LF, Souza AH, et al. Prospective evalution of pregnant women with suspected acute toxoplasmosis treated in a reference prenatal care clinic at a university teaching hospital in Southern Brazil. Rev Inst Med Trop S Paulo. 2020;62:e46. doi:10.1590/S1678-9946202062046.
16. Moura FL, Goulart PRM, Moura APP, Souza TS, Fonseca ABM, Amendoeira MRR. Factors associated to toxoplasmosis-related knowledge among pregnant women attending public health services in the municipality of Niterói, Rio de Janeiro, Brazil, 2013-2015. Epidemiol Serv Saude. 2016;25(3):655-61. doi:10.5123/S1679-49742016000300022.
17. Laboudi M. Review of toxoplasmosis in Morocco: seroprevalence and risk factors for toxoplasma infection among pregnant women and HIV-infected patients. Pan Afr Med J. 2017;27:269. doi:10.11604/pamj.2017.27.269.11822.
18. Marques BL, Tomasi YT, Saraiva SS, Boing AF, Geremia DS. Guidelines to pregnant women: the importance of the shared care in primary health care. Esc Anna Nery. 2021;25(1):e20200098. doi:10.1590/2177-9465-ean-2020-0098.
19. Mejia-Oquendo M, Marulanda E, Gomez-Marin J. Evaluation of the impact of the first evidence-based guidelines for congenital toxoplasmosis: an observational retrospective analysis. Lancet Reg Health-Am. 2021;1:100010. doi:10.1016/j.lana.2021.100010.
20. Amendoeira MRA, Camillo-Coura LF. Uma breve revisão sobre toxoplasmose na gestação. Scientia Medica. 2010;20(1):113-9.
21. Ministério da Saúde. Nota Técnica Nº 4/2022-DAPES/SAPS/MS. Proporção de gestantes com pelo menos 6 (seis) consultas pré-natalrealizadas, sendo a 1ª até a 12 ª semana de gestação. [Internet]. Brasília, DF: Ministério da Saúde; 2020 [cited 2023 Nov 4]. Available from: https://www.conasems.org.br/wp-content/uploads/2022/01/Proporcao-de-gestantes-com-pelomenos-
6-seis-consultas-pre-natal.pdf
22. Villar BBLF, Neves ES, Louro VC, Lessa JF, Rocha DN, Gomes LHF, et al. Toxoplasmosis in pregnancy: a clinical, diagnostic, and epidemiological study in a referral hospital in Rio de Janeiro, Brazil. Braz J Infect Dis. 2020;24(6):517-23. doi:10.1016/j.bjid.2020.10.001.
23. Gargaté MJ, Ferreira I, Vilares A, Martins S, Cardoso C, Silva S, et al. Toxoplasma gondii seroprevalence in the Portuguese population: comparison of three cross-sectional studies spanning three decades. BMJ Open. 2016;6(10):e011648. doi:10.1136/
bmjopen-2016-011648. Arch. Health. Sci. 2025. Toxoplasma and Toxoplasmosis | DOI: 10.17696/2318-3691.31.01.2025.226 | e310125226 7
24. Ministério da Saúde. Nota Técnica Nº 14/2020-COSMU/CGCIVI/DAPES/SAPS/MS. Trata-se de Nota Técnica que apresenta fluxograma de diretriz Nacional, para a condução clínica do diagnóstico e tratamento da Toxoplasmose Gestacional e Congênita [Internet]. Brasília,
DF: Ministério da Saúde; 2020 [cited 2023 Oct 30]. Available from: https://saude.rs.gov.br/upload/arquivos/202112/17150626-nota-tecnica-n-14-2020-cosmu-cgcivi-dapes-sapsms-2.pdf
25. Soares JAS, Holzmann APF, Alves BBS, Lima CFQ, Caldeira AP. Perfil de gestantes e crianças acompanhadas por exposição ao Toxoplasma gondii num centro de referência: o que mudou 10 anos depois? Rev Bras Saúde Mater Infant. 2023;23:e20220225. doi:10.1590/1806-9304202300000225.
26. Falcão CMMB, Sousa AMA, Moura WL, Batista LIV. Clinical and epidemiological profile of children with congenital toxoplasmosis in a reference institute of perinatology. Res Soc Dev. 2021;10(17):e81101724524. doi:10.33448/rsd-v10i17.24524.
27. Esposti CDD, Santos-Neto ET, Oliveira AE, Travassos C, Pinheiro RS. Desigualdades sociais e geográficas no desempenho da assistência pré-natal de uma Região Metropolitana do Brasil. Ciênc Saúde Coletiva. 2020;25(5):1735-49. doi:10.1590/1413-81232020255.32852019.
28. Mallmann MB, Boing AF, Tomasi YT, Anjos JC, Boing AC. Evolução das desigualdades socioeconômicas na realização de consultas de pré-natal entre parturientes brasileiras: análise do período 2000-2015. Epidemiol Serv Saude. 2018;27(4):7-11. doi:10.5123/S1679-
49742018000400014.
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2025 Arquivos de Ciências da Saúde
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
